Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-04-22 @ 7:46 PM
Study NCT ID:
NCT05283135
Status:
COMPLETED
Last Update Posted:
2025-10-24
First Post:
2022-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High Dose Risankizumab for Psoriasis
Sponsor:
Oregon Medical Research Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
B20-433
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |